Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma

Marta Penas-Prado, Kenneth R. Hess, Michael J. Fisch, Lore W. Lagrone, Morris D. Groves, Victor A. Levin, John F. De Groot, Vinay K. Puduvalli, Howard Colman, Gena Volas-Redd, Pierre Giglio, Charles A. Conrad, Michael E. Salacz, Justin D. Floyd, Monica E. Loghin, Sigmund H. Hsu, Javier Gonzalez, Eric L. Chang, Shiao Y. Woo, Anita MahajanKenneth D. Aldape, W. K.Alfred Yung, Mark R. Gilbert

Research output: Contribution to journal › Article › peer-review

58 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences